Literature DB >> 3460520

Synthesis and antibacterial activities of optically active ofloxacin.

I Hayakawa, S Atarashi, S Yokohama, M Imamura, K Sakano, M Furukawa.   

Abstract

Two optically active (100% enantiomeric excess) isomers of ofloxacin [(+/-)-ofloxacin; DL-8280; (+/-)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7 H-pyrido[1,2,3-de] [1,4] benzoxazine-6-carboxylic acid] were prepared by use of their optically resolved synthetic intermediates. One of the isomers, (-)-ofloxacin, was 8 to 128 times more potent in inhibiting the multiplication of gram-positive and gram-negative bacteria than the other, (+)-ofloxacin, and approximately two times more active than the racemate, (+/-)-ofloxacin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3460520      PMCID: PMC180386          DOI: 10.1128/AAC.29.1.163

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

Authors:  G Y LESHER; E J FROELICH; M D GRUETT; J H BAILEY; R P BRUNDAGE
Journal:  J Med Pharm Chem       Date:  1962-09

2.  Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.

Authors:  A Sugino; C L Peebles; K N Kreuzer; N R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

Review 3.  Development of antibacterial agents of the nalidixic acid type.

Authors:  R Albrecht
Journal:  Prog Drug Res       Date:  1977

4.  Synthesis and antibacterial activities of substituted 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acids.

Authors:  I Hayakawa; T Hiramitsu; Y Tanaka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-12       Impact factor: 1.645

5.  Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.

Authors:  H Agui; T Mitani; A Izawa; T Komatsu; T Nakagome
Journal:  J Med Chem       Date:  1977-06       Impact factor: 7.446

6.  Synthesis of Sch 29482--a novel penem antibiotic.

Authors:  A K Ganguly; V M Girijavallabhan; S McCombie; P Pinto; R Rizi; P D Jeffrey; S Lin
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

7.  Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships.

Authors:  M P Wentland; D M Bailey; J B Cornett; R A Dobson; R G Powles; R B Wagner
Journal:  J Med Chem       Date:  1984-09       Impact factor: 7.446

  7 in total
  48 in total

1.  Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans.

Authors:  K Shiba; O Sakai; J Shimada; O Okazaki; H Aoki; H Hakusui
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.

Authors:  J M Entenza; J Vouillamoz; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.

Authors:  J S Wolfson; D C Hooper; E Y Ng; K S Souza; G L McHugh; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

4.  In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.

Authors:  D Gargallo-Viola; M Esteve; S Llovera; X Roca; J Guinea
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

5.  A novel three-component reaction for the synthesis of 3-aryl-4H-benzo [1,4] oxazin-2-amine.

Authors:  Majid M Heravi; Bita Baghernejad; Hossein A Oskooie
Journal:  Mol Divers       Date:  2009-02-21       Impact factor: 2.943

6.  Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases.

Authors:  K Hoshino; K Sato; K Akahane; A Yoshida; I Hayakawa; M Sato; T Une; Y Osada
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 7.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 8.  DNA gyrase, topoisomerase IV, and the 4-quinolones.

Authors:  K Drlica; X Zhao
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

Review 9.  Marine Bacterial Esterases: Emerging Biocatalysts for Industrial Applications.

Authors:  Noora Barzkar; Muhammad Sohail; Saeid Tamadoni Jahromi; Mohsen Gozari; Sajjad Poormozaffar; Reza Nahavandi; Mahmoud Hafezieh
Journal:  Appl Biochem Biotechnol       Date:  2021-01-07       Impact factor: 2.926

10.  Characterization and its potential application of two esterases derived from the arctic sediment metagenome.

Authors:  Jeong Ho Jeon; Jun-Tae Kim; Sung Gyun Kang; Jung-Hyun Lee; Sang-Jin Kim
Journal:  Mar Biotechnol (NY)       Date:  2008-09-24       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.